Erika J Lampert

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal for immunotherapy of cancer

Cleveland Clinic

Duke University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cleveland Clinic Jun 17 2020

United States

Medical Resident :: Obstetrics and Gynecology

National Cancer Institute

United States

Medical Research Scholars Program, Research Fellow :: Women's Malignancies Branch

Fulbright Association

Spain

Fulbright Research Scholar :: Hospital Clinic of Barcelona

Education History

Duke University

United States

BSC

Publications

Erika J Lampert, Jennifer L Hansen, Surabhi Tewari, Meng Yao, Laura M Chambers, Roberto Vargas, Mariam M AlHilli
Higher incidence of venous thromboembolism associated with increasing lines of treatment in heavily treated ovarian cancer patients. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Erika J Lampert, Jennifer L Hansen, Surabhi Tewari, Meng Yao, Laura M Chambers, Roberto Vargas, Mariam M AlHilli
Higher incidence of venous thromboembolism associated with increasing lines of treatment in heavily treated ovarian cancer patients. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Erika J Lampert, Peter G Rose, Meng Yao, Robert DeBernardo, Roberto J Vargas, Chad M Michener, Laura M Chambers
Efficacy and toxicity of carboplatin and gemcitabine administered on day 1 and day 8 (day1&8) versus day 1-only for platinum-sensitive recurrent epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Erika J Lampert, Ashley Cimino-Mathews, Joo Sang Lee, Jayakumar Nair, Min-Jung Lee, Akira Yuno, Daniel An, Jane B Trepel, Fiorella Schischlik, Jung-Min Lee
Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Journal for immunotherapy of cancer 8 (2) (2021)
Erika J Lampert, Alexandra S Zimmer, Michelle Padget, Ashley Cimino-Mathews, Jayakumar R Nair, Yingmiao Liu, Elizabeth M Swisher, James W Hodge, Andrew B Nixon, Erin Nichols, Mohammad Hadi Bagheri, Elliott Levy, Marc R Radke, Stanley Lipkowitz, Christina M Annunziata, Janis M Taube, Seth M Steinberg, Jung-Min Lee
Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (16) (2020)

Erika J Lampert.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Erika J Lampert